These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24475675)

  • 21. Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study).
    Völler H; Glatz J; Taborski U; Bernardo A; Dovifat C; Heidinger K
    Z Kardiol; 2005 Mar; 94(3):182-6. PubMed ID: 15747040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients.
    Dauphin C; Legault B; Jaffeux P; Motreff P; Azarnoush K; Joly H; Geoffroy E; Aublet-Cuvelier B; Camilleri L; Lusson JR; Cassagnes J; de Riberolles C
    Arch Cardiovasc Dis; 2008; 101(11-12):753-61. PubMed ID: 19059570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term oral anticoagulation. Evidence favors self management].
    Westphal K
    MMW Fortschr Med; 2004 Oct; 146(42):58-9. PubMed ID: 15536709
    [No Abstract]   [Full Text] [Related]  

  • 24. ARISTOTLE expands the list of novel anticoagulants for thromboprophylaxis in atrial fibrillation.
    Tzeis S; Andrikopoulos G
    Angiology; 2012 Oct; 63(7):558-9. PubMed ID: 22669951
    [No Abstract]   [Full Text] [Related]  

  • 25. New oral anticoagulants in development.
    Weitz JI
    Thromb Haemost; 2010 Jan; 103(1):62-70. PubMed ID: 20062934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes.
    Bloomfield HE; Krause A; Greer N; Taylor BC; MacDonald R; Rutks I; Reddy P; Wilt TJ
    Ann Intern Med; 2011 Apr; 154(7):472-82. PubMed ID: 21464349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anticoagulation in atrial fibrillation. Strategies in special situations].
    Volkmann H; Walter M; Walter C; Vetter S
    Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Warfarin for stroke prevention in atrial fibrillation: time to switch?
    Ahmad Y; Lip GY
    Int J Clin Pract; 2013 Jul; 67(7):603-5. PubMed ID: 23758442
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.
    Liew A; Eikelboom JW; O'Donnell M; Hart RG
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S34-44. PubMed ID: 23790596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Optimizing long-term anticoagulation by patient self-management?].
    Bernardo A
    Z Kardiol; 1998; 87 Suppl 4():75-81. PubMed ID: 9857471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
    J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.
    Singer DE; Fang MC; Go AS
    Arch Intern Med; 2009 Nov; 169(21):2032; author reply 2033. PubMed ID: 19933969
    [No Abstract]   [Full Text] [Related]  

  • 33. [Oral anticoagulants. Large study finds minor risk of hemorrhage in the elderly].
    MMW Fortschr Med; 2011 Sep; 153(37):16. PubMed ID: 21950182
    [No Abstract]   [Full Text] [Related]  

  • 34. Bleeding risk during oral anticoagulation therapy for atrial fibrillation.
    Gallego P; Lip GY; Lane DA
    Europace; 2013 Jun; 15(6):773-4. PubMed ID: 23537615
    [No Abstract]   [Full Text] [Related]  

  • 35. Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.
    Lane DA; Lip GY
    Thromb Haemost; 2009 May; 101(5):802-5. PubMed ID: 19404530
    [No Abstract]   [Full Text] [Related]  

  • 36. [Monitoring of anticoagulation--management in practice].
    Schinzel H; Weilemann LS
    Dtsch Med Wochenschr; 2014 Jan; 139 Suppl 1():S27-30. PubMed ID: 24446039
    [No Abstract]   [Full Text] [Related]  

  • 37. [Discontinuing oral anticoagulation for elective surgical interventions].
    Marzan A; Ulrich Somaini S; Bächli E
    Praxis (Bern 1994); 2011 Nov; 100(23):1387-92; quiz 1393-5. PubMed ID: 22086376
    [No Abstract]   [Full Text] [Related]  

  • 38. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
    Garwood CL; Hwang JM; Moser LR
    Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New options in the treatment of atrial fibrillation].
    Völler H
    Dtsch Med Wochenschr; 2013 Dec; 138(50):2579. PubMed ID: 24301489
    [No Abstract]   [Full Text] [Related]  

  • 40. Self-testing of the International Normalized Ratio in adults with a mechanical heart valve: patient education and cost matter.
    Henaine R; Chevalier P; Henaine AM; Motreff P; Pozzi M; Armoiry X
    Thromb Res; 2014 Feb; 133(2):129-30. PubMed ID: 24331210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.